Ramon Felciano, CTO and Vice President, Technology and Global Strategy
Global Manager, Clinical Testing Solutions, QIAGEN Bioinformatics
Kristina Kermanshahche, Global Director of Life Sciences, Intel
Are you interested in NGS-based genetic testing across a range of cancer, hereditary, and rare diseases?
Learn how a leading academic hospital used a robust informatics platform to accelerate the deployment of validated precision medicine capabilities from sample to insight.
QIAGEN provides an instrument-, platform-, assay- and pipeline-agnostic solution, that enables health care providers to scale sequencing, analysis, interpretation and reporting of screening, diagnostic and monitoring test offerings, fully integrated with hospital information systems.
Join the discussion on the importance of cost-effective and automated approaches for scaling an organizational capacity for analysis, classification and clinical reporting of relevant variants for delivery to physician providers.
Lunch and refreshments will be served.